Clinical Trials Browser

Phase 2 × INDUSTRY × Smoldering Multiple Myeloma × Clear all

NCT05955508 2026-04-13

A Proof-of-Concept Trial to Study the Safety and Activity of Linvoseltamab in Adult Participants With Smoldering Multiple Myeloma at High Risk of Developing Multiple Myeloma

Phase 2 Active not recruiting

Smoldering Multiple Myeloma, Multiple Myeloma

NCT06140524 2026-04-08

LINKER-MGUS1

Phase 2 Recruiting

Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance

NCT02316106 2025-04-27

A Study to Evaluate 3 Dose Schedules of Daratumumab in Participants With Smoldering Multiple Myeloma

Phase 2 Completed

Smoldering Multiple Myeloma, Multiple Myeloma

NCT01838369 2023-01-11

A Phase II Study of BI-505 in Smoldering Multiple Myeloma

Phase 2 Terminated

Smoldering Multiple Myeloma

NCT01302886 2020-12-17

Study of BHQ880 in Patients With High Risk Smoldering Multiple Myeloma

Phase 2 Completed

Smoldering Multiple Myeloma

NCT01441973 2018-01-23

Biomarker Study of Elotuzumab in High Risk Smoldering Myeloma

Phase 2 Completed

41 enrolled 17 charts

Smoldering Multiple Myeloma

NCT01222286 2014-05-09

KIRMONO

Phase 2 Completed

30 enrolled 10 charts

Smoldering Multiple Myeloma